Overbrook Management Corp’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$366K	Hold	11,537	–	–	0.07%	44
2025 Q4	$313K	Buy	11,537 +2,740	+31%	+$72.2K	0.05%	43
2025 Q3	$228K	Buy	+8,797	New	+$204K	0.04%	44
2024 Q4	–	Sell	-6,837	Closed	-$232K	–	53
2024 Q3	$232K	Hold	6,837	–	–	0.05%	51
2024 Q2	$253K	Sell	6,837 -252	-4%	-$9.51K	0.06%	50
2024 Q1	$298K	Sell	7,089 -555	-7%	-$22.8K	0.08%	51
2023 Q4	$303K	Hold	7,644	–	–	0.06%	55
2023 Q3	$210K	Sell	7,644 -119	-2%	-$3.73K	0.05%	58
2023 Q2	$263K	Hold	7,763	–	–	0.06%	59
2023 Q1	$279K	Sell	7,763 -312	-4%	-$13.5K	0.07%	63
2022 Q4	$360K	Hold	8,075	–	–	0.1%	56
2022 Q3	$227K	Sell	8,075 -165	-2%	-$5.06K	0.06%	69
2022 Q2	$222K	Hold	8,240	–	–	0.06%	78
2022 Q1	$281K	Buy	+8,240	New	+$263K	0.06%	77
2019 Q1	–	Sell	-3,241	Closed	-$10K	–	71
2018 Q4	$10K	Hold	3,241	–	–	﹤0.01%	71
2018 Q3	$22K	Hold	3,241	–	–	﹤0.01%	74
2018 Q2	$24K	Hold	3,241	–	–	﹤0.01%	72
2018 Q1	$113K	Hold	3,241	–	–	0.02%	75
2017 Q4	$138K	Hold	3,241	–	–	0.03%	76
2017 Q3	$139K	Sell	3,241 -500	-13%	-$18.7K	0.03%	70
2017 Q2	$139K	Buy	+3,741	New	+$165K	0.03%	77